Trials / Sponsors / Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2019-06-21 |
| Completed | Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention Metastatic Melanoma | Phase 1 | 2019-01-28 |
| Completed | Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer Advanced Metastatic Cancer, Advanced Prostate Cancer | Phase 2 | 2018-10-17 |
| Completed | Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2017-07-21 |
| Completed | Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed Melanoma | Phase 2 | 2016-06-21 |